粒子束治疗与立体定向体部放疗治疗早期非小细胞肺癌的系统综述与假设生成meta分析
该系统综述与假设生成meta分析纳入72项SBRT研究和9项低分次粒子束治疗研究(多为单臂),比较早期非小细胞肺癌的生存、毒性和失败模式;单因素分析中粒子束治疗与总生存和无进展生存改善相关,但多因素校正可手术性后总生存获益未达统计学显著性,3年局部控制仍支持粒子束治疗。
要点
- 单因素meta分析中粒子束治疗与总生存改善(p=0.005)和无进展生存改善(p=0.01)相关。
- 多因素meta分析纳入可手术性后总生存获益未达统计学显著性(p=0.11)。
- 3年局部控制仍支持粒子束治疗(p=0.03)。
核心结论
- 低分次粒子束治疗相比光子SBRT可能带来额外临床获益,但校正潜在混杂因素后未观察到统计学显著的生存获益。
研究设计与样本
- 系统检索PubMed、Medline、Google-scholar和Cochrane图书馆数据库2000至2016年文献,纳入早期非小细胞肺癌的原始英文研究。
- 共纳入72项SBRT研究和9项低分次粒子束治疗研究(多为单臂),进行meta分析比较生存结局、毒性特征和失败模式。
主要发现
- 单因素meta分析中粒子束治疗与总生存改善相关(p=0.005)。
- 单因素meta分析中粒子束治疗与无进展生存改善相关(p=0.01)。
- 将可手术性纳入最终多因素meta分析后,总生存获益未达统计学显著性(p=0.11)。
- 3年局部控制仍支持粒子束治疗(p=0.03)。
临床怎么用
- 该假设生成meta分析提示粒子束治疗在早期非小细胞肺癌中局部控制可能优于光子SBRT,但生存获益需校正混杂因素后进一步验证。
局限性
- 纳入的粒子束治疗研究多为单臂,证据级别有限。
- 该分析为假设生成性质,结论需前瞻性研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess hypo-fractionated particle beam therapy (PBT)'s efficacy relative to that of photon stereotactic body radiotherapy (SBRT) for early stage (ES) non-small cell lung cancer (NSCLC). METHODS: Eligible studies were identified through extensive searches of the PubMed, Medline, Google-scholar, and Cochrane library databases from 2000 to 2016. Original English publications of ES NSCLC were included. A meta-analysis was performed to compare the survival outcome, toxicity profile, and patterns of failure following each treatment. RESULTS: 72 SBRT studies and 9 hypo-fractionated PBT studies (mostly single-arm) were included. PBT was associated with improved overall survival (OS; p=0.005) and progression-free survival (PFS; p=0.01) in the univariate meta-analysis. The OS benefit did not reach its statistical significance after inclusion of operability into the final multivariate meta-analysis (p=0.11); while the 3-year local control (LC) still favored PBT (p=0.03). CONCLUSION: Although hypo-fractionated PBT may lead to additional clinical benefit when compared with photon SBRT, no statistically significant survival benefit from PBT over SBRT was observed in the treatment of ES NSCLC in this hypothesis-generating meta-analysis after adjusting for potential confounding variables.
引用
- Chi A, Chen H, Wen S, et al. Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis. Radiother Oncol. 2017. PMID: 28545956. doi:10.1016/j.radonc.2017.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。